S. Marieke van Ham

Generation of dendritic cells for immunotherapy is minimally impaired by granulocytes in the monocyte preparation.

A. ten Brinke, H. Vrielink, J. Zwaginga, 2006, Immunobiology.

Hurdles in therapy with regulatory T cells

Andrew Bushell, Anja ten Brinke, Giovanna Lombardi, 2015, Science Translational Medicine.

IL-21-stimulated human plasmacytoid dendritic cells secrete granzyme B, which impairs their capacity to induce T-cell proliferation.

J. Karrich, B. Blom, L. Jachimowski, 2013, Blood.

Detection of aberrant transcription of major histocompatibility complex class II antigen presentation genes in chronic lymphocytic leukaemia identifies HLA‐DOA mRNA as a prognostic factor for survival

C. Meijer, J. Neefjes, G. Ossenkoppele, 2009, British journal of haematology.

Tumor immune escape in acute myeloid leukemia

G. Ossenkoppele, A. A. van de Loosdrecht, M. M. van Luijn, 2012, Oncoimmunology.

Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations

P. van Paassen, F. Bemelman, G. D'Haens, 2023, Journal of Autoimmunity.

Redefining Strategies to Introduce Tolerance-Inducing Cellular Therapy in Human beings to Combat Autoimmunity and Transplantation Reactions

Anja ten Brinke, Irma Joosten, S. Marieke van Ham, 2014, Front. Immunol..

IL-21-stimulated human plasmacytoid dendritic cells secrete granzyme B, which impairs their capacity to induce T-cell proliferation.

J. Karrich, B. Blom, L. Jachimowski, 2013, Blood.